Embecta Corp

Chart & Performance

D1W1MN

P/E

1.98

P/S

0.17

EPS

1.61

Div Yield, %

18.81%

Shrs. gr., 5y

0.66%

Rev. gr., 5y

-0.09%

Revenues

1.08b

-3.80%

Net income

95m

+21.84%

CFO

192m

+436.97%

Dividend

Dec 05, 20250.15 USD/sh

Notes

No notes on this company yet

Write a private note on this company, for your eyes only

Add note

Profile

Embecta Corp. is a medical technology enterprise devoted to enhancing the quality of life and health outcomes for individuals living with diabetes. Its comprehensive product portfolio includes essential tools such as pen needles, syringes, and advanced safety devices. Additionally, the company provides innovative digital applications designed to support patients in effectively managing their condition. Embecta distributes its offerings primarily through a network of wholesalers and distributors, reaching markets both domestically within the United States and across the globe. Established in 1924, Embecta's headquarters are located in Parsippany, New Jersey. The company transitioned to an independent entity from Becton, Dickinson and Company on April 1, 2022.

URL

https://www.embecta.com/

IPO date

Mar 21, 2022

Employees

1,900

Domiciled in

Incorporated in

Valuation

Order:

Title USD in thousands, except ratios and share amounts	FY	FY	FY	FY	FY	FY	FY
Title USD in thousands, except ratios and share amounts	2025‑09	2024‑09	2023‑09	2022‑09	2021‑09	2020‑09	2019‑09
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT